Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL667P is a processed pseudogene derived from the 7SL RNA gene family, which normally encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein crucial for cotranslational targeting of secretory proteins to the endoplasmic reticulum. However, this particular locus, as with most 7SL RNA pseudogenes, does not produce a functional RNA and is not expressed or involved in any known biological process. 7SL RNA pseudogenes commonly arise from the reverse transcription of the 7SL RNA and subsequent integration into the genome, lacking the necessary regulatory elements for transcription and function. RN7SL667P has no reported role as a receptor, enzyme, transporter, or therapeutic target and is best classified as a non-functional genomic element.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 667, pseudogene (RN7SL667P).